| Description | Date | Size |
|---|
| Section 01: Introduction (Download) | 2019-10-01 | 202.47 KB |
| Section 01: Participant Accrual and Retention (Download) | 2019-10-01 | 225.22 KB |
| Section 02: Documentation Requirements (Download) | 2019-10-01 | 222 KB |
| Section 04: Informed Consent (Download) | 2019-10-01 | 341.74 KB |
| Section 05: Study Procedures (Download) | 2019-10-01 | 563.54 KB |
| Section 06: Study Product Considerations for Non-Pharmacy Staff (Download) | 2019-10-18 | 843.62 KB |
| Section 07: Clinical Considerations (Download) | 2019-10-18 | 748.61 KB |
| Section 08: Adverse Event Reporting and Safety Monitoring (Download) | 2019-10-18 | 756.71 KB |
| Section 09: Counseling Considerations (Download) | 2019-10-01 | 352.24 KB |
| Section 10: Laboratory Considerations (Download) | 2019-10-01 | 734.16 KB |
| Section 11: Data Collection (Download) | 2019-10-10 | 774.15 KB |
| Section 12: Data Communiqués (Download) | 2019-10-10 | 136.22 KB |
| Section 13: Study Reporting Plan (Download) | 2019-10-10 | 300.22 KB |
| Section 14: DELIVER Qualitative Component (Download) | 2019-10-18 | 1001.03 KB |